Good Post, but more Compelling when you Bring the Receipts

https://x.com/casebradford/status/2026384289743429782

Full Circle

In September 2016, German chemical company Bayer announced its intent to acquire Monsanto for US$66 billion in an all-cash deal. After gaining U.S. and EU regulatory approval, the sale was completed on June 7, 2018. The name Monsanto was no longer used, but Monsanto's previous product brand names were maintained.

Bayer completes biggest acquisition in its history

https://www.bayer.com/media/en-us/bayer-completes-biggest-acquisition-in-its-history/

In 2015, the International Agency for Research on Cancer (IARC) concluded that glyphosate and GBFs are carcinogenic to humans (group 2A), mainly for non-Hodgkin lymphoma (NHL).

Exposure to Glyphosate-Based Herbicides and Risk for Non-Hodgkin Lymphoma: A Meta-Analysis and Supporting Evidence (NIH)

https://pmc.ncbi.nlm.nih.gov/articles/PMC6706269/

On Oct. 14, 2020 Bayer announced the Phase III study results of its new drug Copanlisib in combination with Rituximab in patients with relapsed indolent non-Hodgkin's lymphoma. Bayer said the combination significantly prolongs progression-free survival.

Monsanto announces Roundup™ class settlement agreement to resolve current and future claims (February 17, 2026)

Funding of the class is up to $7.25 Billion

https://www.bayer.com/en/investors/bayer-investor-and-media-update

Bayer annual gross profit for 2024 was $27.416B, a 9.17% decline from 2023. Bayer annual gross profit for 2023 was $30.183B, a 7.19% decline from 2022. Bayer annual gross profit for 2022 was $32.523B, a 0.82% increase from 2021

Watch 2025 (For all the Pure Bloods out there), do you think the Profits will be Higher or Lower than 2024